KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Profit After Tax Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -27.80%
Dec 31, 2025 119.06%
Sep 30, 2025 -39.60%
Jun 30, 2025 26.73%
Mar 31, 2025 -15.60%
Dec 31, 2024 -14.96%
Sep 30, 2024 -3.69%
Jun 30, 2024 13.13%
Mar 31, 2024 -11.03%
Dec 31, 2023 19.63%
Sep 30, 2023 -8.33%
Jun 30, 2023 0.41%
Mar 31, 2023 -38.69%
Dec 31, 2022 116.49%
Sep 30, 2022 19.35%
Jun 30, 2022 -13.56%
Mar 31, 2022 21.28%
Dec 31, 2021 23.79%
Sep 30, 2021 14.75%
Jun 30, 2021 -13.81%
Mar 31, 2021 21.28%
Dec 31, 2020 -52.68%
Sep 30, 2020 13.30%
Jun 30, 2020 -20.50%
Mar 31, 2020 24.11%
Dec 31, 2019 40.41%
Sep 30, 2019 30.07%
Jun 30, 2019 -7.56%
Mar 31, 2019 20.17%
Dec 31, 2018 -24.92%
Sep 30, 2018 23.30%
Jun 30, 2018 13.17%
Mar 31, 2018 23.52%
Dec 31, 2017 -49.88%
Sep 30, 2017 0.57%
Jun 30, 2017 8.61%
Mar 31, 2017 14.15%